Lemaitre Vascular Inc (LMAT) — 10-Q Filings
All 10-Q filings from Lemaitre Vascular Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
LeMaitre Vascular Q3 Net Income Soars 56% on Strong Sales, ERC Boost
— Nov 7, 2025 Risk: medium
LEMAITRE VASCULAR INC reported robust financial performance for the three and nine months ended September 30, 2025. Net sales increased by 11.3% to $61.046 mill -
Lemaitre Vascular Posts Strong Q2 Growth, Net Income Jumps 25%
— Aug 6, 2025 Risk: low
LEMAITRE VASCULAR INC reported a robust financial performance for the six months ended June 30, 2025, with total revenue reaching $80.0 million, a significant i -
Lemaître Vascular Q1 2025 Update
— May 8, 2025 Risk: low
Lemaître Vascular Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's financial performance for the first quarter o -
Lemaître Vascular Files Q3 2024 10-Q
— Nov 8, 2024 Risk: low
Lemaître Vascular Inc. reported its Q3 2024 results, with the filing period ending September 30, 2024. The company's fiscal year ends on December 31st. Key fina -
Lemaître Vascular Q2 2024: OCI Up Slightly
— Aug 8, 2024 Risk: low
Lemaître Vascular Inc. reported its Q2 2024 results, ending June 30, 2024. The company's financial statements show accumulated other comprehensive income of $10 -
LEMAITRE VASCULAR INC Files 10-Q for Q1 2024
— May 10, 2024 Risk: low
LEMAITRE VASCULAR INC (LMAT) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Revenue for the three months ended March 31, 2024, was $51.3 million.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX